These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29878688)

  • 21. Impact of induction strategy change on first-year rejection in pediatric heart transplantation at a single center-From postoperative basiliximab to either postoperative anti-thymocyte globulin or preoperative basiliximab.
    Sisson TM; Padilla LA; Hubbard M; Smith S; Pearce FB; Collins JL; Carlo WF
    Clin Transplant; 2021 Jun; 35(6):e14314. PubMed ID: 33838071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of immunosuppression induction with basiliximab compared to antithymocyte-globulin in adult heart transplant patients.
    Eberhardt TE; Kim DH; Nethersole S; Pearson GJ
    Clin Transplant; 2024 Jun; 38(6):e15332. PubMed ID: 38804609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2005 Sep; 24(9):1320-6. PubMed ID: 16143251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of single-dose anti-thymocyte globulin versus basiliximab induction therapy in pediatric kidney transplant recipients: A retrospective comparative cohort study.
    Custodio LFP; Martins SBS; Viana LA; Cristelli MP; Requião-Moura L; Chow CYZ; Camargo SFDN; Nakamura MR; Foresto RD; Tedesco-Silva H; Medina-Pestana J
    Pediatr Transplant; 2024 May; 28(3):e14713. PubMed ID: 38553819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Induction Therapy on Graft Survival in Primary Pediatric Heart Transplantation: A Propensity Score Analysis of the UNOS Database.
    Butts R; Davis M; Savage A; Burnette A; Kavarana M; Bradley S; Atz A; Nietert PJ
    Transplantation; 2017 Jun; 101(6):1228-1233. PubMed ID: 27362312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
    Zang S; Zhang X; Niu J; Das BB
    Clin Transplant; 2023 Jan; 37(1):e14836. PubMed ID: 36259556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients.
    Brokhof MM; Sollinger HW; Hager DR; Muth BL; Pirsch JD; Fernandez LA; Bellingham JM; Mezrich JD; Foley DP; D'Alessandro AM; Odorico JS; Mohamed MA; Vidyasagar V; Ellis TM; Kaufman DB; Djamali A
    Transplantation; 2014 Mar; 97(6):612-7. PubMed ID: 24531846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential rates of ischemic cholangiopathy and graft survival associated with induction therapy in DCD liver transplantation.
    Halldorson JB; Bakthavatsalam R; Montenovo M; Dick A; Rayhill S; Perkins J; Reyes J
    Am J Transplant; 2015 Jan; 15(1):251-8. PubMed ID: 25534449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
    Lee H; Lee S; Jeon JS; Kwon SH; Noh H; Han DC; Yun S; Song D
    Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A contemporary analysis of induction immunosuppression in pediatric lung transplant recipients.
    Hayes D; Kirkby S; Wehr AM; Lehman AM; McConnell PI; Galantowicz M; Higgins RS; Whitson BA
    Transpl Int; 2014 Feb; 27(2):211-8. PubMed ID: 24236829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.
    Clinckart F; Bulpa P; Jamart J; Eucher P; Delaunois L; Evrard P
    Transplant Proc; 2009 Mar; 41(2):607-9. PubMed ID: 19328937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients.
    Montenovo MI; Jalikis FG; Li M; Yeh M; Dick A; Hansen R; Reyes JD
    Exp Clin Transplant; 2017 Aug; 15(4):425-431. PubMed ID: 27309029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
    Lentine KL; Schnitzler MA; Xiao H; Brennan DC
    Trials; 2015 Aug; 16():365. PubMed ID: 26285695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
    Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
    Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.
    Huang HF; Zhou JY; Xie WQ; Wu JY; Deng H; Chen JH
    Int Urol Nephrol; 2016 Aug; 48(8):1363-1370. PubMed ID: 27170340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W
    Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of clinical outcomes between antithymocyte globulin and basiliximab in renal transplantation from donation after citizen death: a matched pair study].
    Lin KL; Zhu L; Fu C; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):99-103. PubMed ID: 28088952
    [No Abstract]   [Full Text] [Related]  

  • 40. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC
    J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.